DVT
Akura Medical, A New Shifamed Portfolio Company, Closes $25M in an Oversubscribed Series A1 Financing
The financing was led by Cormorant Asset Management, with participation from The Capital Partnership (TCP), PA MedTech VC Fund and Shifamed angel investors.